TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
DrugtestScandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
254
|
252
|
210 |
| Financial expenses |
0
|
0
|
3 |
| Earnings before taxes |
-52
|
-28
|
-2 |
| EBITDA |
-52
|
-29
|
0 |
| Total assets |
73
|
120
|
172 |
| Current assets |
73
|
120
|
149 |
| Current liabilities |
116
|
111
|
73 |
| Equity capital |
-43
|
9
|
99 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-58.9%
|
7.5%
|
57.6% |
| Turnover per employee |
254
|
126
|
105 |
| Profit as a percentage of turnover |
-20.5%
|
-11.1%
|
-1.0% |
| Return on assets (ROA) |
-71.2%
|
-23.3%
|
0.6% |
| Current ratio |
62.9%
|
108.1%
|
204.1% |
| Return on equity (ROE) |
120.9%
|
-311.1%
|
-2.0% |
| Change turnover |
10
|
42
|
53 |
| Change turnover % |
4%
|
20%
|
34% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.